Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Nexus Surgical and Medicare's 5-Year Yield-on-Cost % or its related term are showing as below:
BOM:538874's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.17 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Nexus Surgical and Medicare (BOM:538874) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Nexus Surgical and Medicare 5-Year Yield-on-Cost % Related Terms
BOM:538874 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Nexus Surgical and Medicare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus Surgical and Medicare 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Nexus Surgical and Medicare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Nexus Surgical and Medicare's 5-Year Yield-on-Cost % falls into.
Nexus Surgical and Medicare 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Nexus Surgical and Medicare (BOM:538874) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nexus Surgical and Medicare and its competitors. According to the industry distribution chart, Nexus Surgical and Medicare ranks #999999 out of 71 companies in the Medical Distribution industry.
Is Nexus Surgical and Medicare's 5-Year Yield-on-Cost % too high?
Nexus Surgical and Medicare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Nexus Surgical and Medicare ranks #999999 out of 71 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Nexus Surgical and Medicare has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nexus Surgical and Medicare's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Nexus Surgical and Medicare ranks #999999 out of 71 companies for 5-Year Yield-on-Cost %. This places Nexus Surgical and Medicare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.17, based on 71 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nexus Surgical and Medicare and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus Surgical and Medicare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus Surgical and Medicare stock overvalued right now?
Based on GuruFocus' analysis, Nexus Surgical and Medicare (BOM:538874) is currently considered Fairly Valued. The stock's GF Value™ is ₹30.81, compared to a current price of ₹33.46 — trading 8.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Nexus Surgical and Medicare's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Nexus Surgical and Medicare (BOM:538874), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus Surgical and Medicare (BOM:538874) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus Surgical and Medicare stock appears to be overvalued.
The current stock price of ₹33.46 is trading 8.6% above its estimated GF Value™ of ₹30.81.
GuruFocus considers Nexus Surgical and Medicare to be Fairly Valued.
Key valuation signals for BOM:538874:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₹30.81 vs. price of ₹33.46 (8.6% above fair value)
No single metric tells the full story. See the BOM:538874 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus Surgical and Medicare Ltd is involved in Importing and Marketing Quality Surgical and Pharmaceutical Products at an Economical Price. The Company is a wholesale dealer dealing in various sizes of disposal syringes (with and without needles) and pouches of various sizes used for the storage of sterilized equipment and materials. It operates in the segment of trading activities.
81GF Score
Get the complete analysis for BOM:538874
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538874 has been successfully added to your 
